Matt Dolan
Senior Vice President of Dexcom in Solana Beach, CA
Matt Dolan is a successful businessman currently residing in San Diego. With more than 15 years of experience working in the medical technology industry, Dolan has become a recognized name in his area.
Matt started his career after graduating from Northwestern University, where he immersed himself in Economics alongside pre-medical studies. Despite his initial interest in healthcare, he found the complexities of economic and business studies more captivating. In 2006, he joined Roth Capital Partners, LLC, an investment bank specializing in emerging growth companies. As a research analyst, his focus on medical companies and industry trends provided valuable insights into market dynamics and transactions. Over nearly a decade with Roth Capital, Matt's contributions led to a promotion to Senior Research Analyst. His impressive track record includes overseeing numerous relationships with medical companies and showcasing his expertise in the field.
He currently serves as both the General Manager of New Markets and Senior Vice President at DexCom Inc. When Matt Dolan first joined DexCom, Inc. he was given the role of Vice President of Corporate Development. In this role, he led the initiation, negotiation, and management of business relationships with medical, pharmaceutical, and technology companies. These partnerships included such major players as Eli Lily.
He oversaw the companies first major strategic investments, providing the organization with several major partnerships and revenue streams. He wasn’t just in it for his immediate success though. Matt developed and presented the board of directors with a long-term strategy and plan that included core business projects and emerging markets as major points of intrigue. He was successful and impressive, and he led a long-term shift in corporate culture. Since starting with DexCom Inc. Dolan has also launched more than 5 commercial offerings, including one into the hospital to support the fight of COVID-19, which helped revenue grow more than 400%.
Press: